Neutralization and durability of 2 or 3 doses of the BNT162b2 vaccine against Omicron SARS-CoV-2-Reference-Cited by-同舟云学术

Neutralization and durability of 2 or 3 doses of the BNT162b2 vaccine against Omicron SARS-CoV-2

Published:2022-04 Issue:4 Volume:30 Page:485-488.e3
ISSN:1931-3128
Container-title:Cell Host & Microbe
language:en
Short-container-title:Cell Host & Microbe

Author:

Xia Hongjie,Zou Jing,Kurhade Chaitanya,Cai Hui,Yang Qi,Cutler Mark,Cooper David,Muik Alexander,Jansen Kathrin U.,Xie Xuping,Swanson Kena A.,Shi Pei-Yong

Publisher

Elsevier BV

Subject

Virology,Microbiology,Parasitology

Reference16 articles.

1. SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection;Cele;medRxiv,2021

2. Synthetic generation of influenza vaccine viruses for rapid response to pandemics;Dormitzer;Sci. Transl. Med.,2013

3. SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3;Falsey;N. Engl. J. Med.,2021

4. BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants;Liu;Nature,2021

5. Neutralizing Activity of BNT162b2-Elicited Serum;Liu;N. Engl. J. Med.,2021

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Brighton Collaboration standardized template with key considerations for a benefit-risk assessment for the Comirnaty COVID-19 mRNA vaccine;Vaccine;2024-09

2. SARS-CoV-2 Vaccines: The Advantage of Mucosal Vaccine Delivery and Local Immunity;Vaccines;2024-07-18

3. Development and evaluation of vaccination strategies for addressing the continuous evolution SARS-CoV-2 based on recombinant trimeric protein technology: Potential for cross-neutralizing activity and broad coronavirus response;Heliyon;2024-07

4. Variant-specific antibody response following repeated SARS-CoV-2 vaccination and infection;Cell Reports;2024-07

5. SARS-CoV-2-Specific Immune Responses in Vaccination and Infection during the Pandemic in 2020–2022;Viruses;2024-03-13